Class | Agent(s) | Comment |
Primary uricosurics | Probenecid, sulfinpyrazone*, benzbromarone*, lesinurad | |
Urate oxidase (uricolytics) | Pegloticase, rasburicase | Converts uric acid to allantoin (inactive water soluble metabolite). |
Drugs with secondary uricosuric effect | ||
Angiotensin-converting enzyme (ACE) inhibitors | Enalapril, captopril | Other ACE inhibitors do not seem to increase uric acid excretion. |
Angiotensin II receptor blocker (ARB) | Losartan | Only ARB that significantly lowers serum uric acid. May counteract uric acid increase due to thiazide or cyclosporine. |
Calcium channel blockers, dihydropyridine | Amlodipine, felodipine, nitrendipine, nicardipine | Shown to decrease serum uric acid in patients taking cyclosporine following renal graft. |
Fibric acid derivative | Fenofibrate (micronized) | Significant uricosuric effect; data are lacking on effect of other fibrates. |
Statins | Atorvastatin | Modest effect; studies of other statins demonstrated inconsistent or no effect. |
Anti-infectives | Trimethoprim-sulfamethoxazole, ampicillin, rifampin, isoniazid | |
Hormone replacement therapy | Estrogen | |
Salicylates (high doses), aspirin, selected NSAIDs | Diflunisal, aspirin (high dose >3 g/day and low dose 75 mg/day), sulindac, phenylbutazone* | Moderate doses of aspirin can cause uric acid retention. |
Sodium-glucose cotransporter 2 (SGLT2) inhibitors | Canagliflozin, dapagliflozin, empagliflozin, ertugliflozin | Effect likely mediated by the inhibitory effect of glycosuria on urate reabsorption. |
Do you want to add Medilib to your home screen?